{"title":"低收入和中等收入国家的癌症负担。","authors":"Sharmila Anandasabapathy, Chite Asirwa, Surbhi Grover, Chemtai Mungo","doi":"10.1038/s41568-023-00659-2","DOIUrl":null,"url":null,"abstract":"As cancer detection rates and therapy successes increase in high-income countries, it is predicted that over the next decade more than 75% of cancer-related deaths will occur in low-income and middle-income countries. Sub-Saharan Africa, which contains many of these countries, is currently unprepared with inadequate screening and detection methods, treatment and palliative care capacity. In this Viewpoint, we asked experts to discuss this burden and what is needed to alleviate it. In this Viewpoint, we asked four experts to discuss the increasing burden of cancer in low- and middle-income countries; they explore the changes that are necessary to improve cancer diagnosis, prevention and treatment within these nations.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"24 3","pages":"167-170"},"PeriodicalIF":72.5000,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cancer burden in low-income and middle-income countries\",\"authors\":\"Sharmila Anandasabapathy, Chite Asirwa, Surbhi Grover, Chemtai Mungo\",\"doi\":\"10.1038/s41568-023-00659-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As cancer detection rates and therapy successes increase in high-income countries, it is predicted that over the next decade more than 75% of cancer-related deaths will occur in low-income and middle-income countries. Sub-Saharan Africa, which contains many of these countries, is currently unprepared with inadequate screening and detection methods, treatment and palliative care capacity. In this Viewpoint, we asked experts to discuss this burden and what is needed to alleviate it. In this Viewpoint, we asked four experts to discuss the increasing burden of cancer in low- and middle-income countries; they explore the changes that are necessary to improve cancer diagnosis, prevention and treatment within these nations.\",\"PeriodicalId\":19055,\"journal\":{\"name\":\"Nature Reviews Cancer\",\"volume\":\"24 3\",\"pages\":\"167-170\"},\"PeriodicalIF\":72.5000,\"publicationDate\":\"2024-02-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41568-023-00659-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41568-023-00659-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Cancer burden in low-income and middle-income countries
As cancer detection rates and therapy successes increase in high-income countries, it is predicted that over the next decade more than 75% of cancer-related deaths will occur in low-income and middle-income countries. Sub-Saharan Africa, which contains many of these countries, is currently unprepared with inadequate screening and detection methods, treatment and palliative care capacity. In this Viewpoint, we asked experts to discuss this burden and what is needed to alleviate it. In this Viewpoint, we asked four experts to discuss the increasing burden of cancer in low- and middle-income countries; they explore the changes that are necessary to improve cancer diagnosis, prevention and treatment within these nations.
期刊介绍:
Nature Reviews Cancer, a part of the Nature Reviews portfolio of journals, aims to be the premier source of reviews and commentaries for the scientific communities it serves. The correct abbreviation for abstracting and indexing purposes is Nat. Rev. Cancer. The international standard serial numbers (ISSN) for Nature Reviews Cancer are 1474-175X (print) and 1474-1768 (online). Unlike other journals, Nature Reviews Cancer does not have an external editorial board. Instead, all editorial decisions are made by a team of full-time professional editors who are PhD-level scientists. The journal publishes Research Highlights, Comments, Reviews, and Perspectives relevant to cancer researchers, ensuring that the articles reach the widest possible audience due to their broad scope.